d) at Acadia Pharmaceuticals

Kiel, Schleswig-Holstein, Germany

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Pharmakant (m/w/d)
At least a good mittlerer Schulabschluss (MSA)
Interest in physical, chemical, mathematical, and technological connections
Interest in pharmaceutical manufacturing processes
Quick perception, enthusiasm for new things, good observation skills
Works well in a team with a careful and responsible work ethic
Good German skills in spoken and written form
Chemielaborant (m/w/d)
Interest in physical, chemical, mathematical, natural science, technical connections, and chemical-physical processes
Appropriate hygiene and quality awareness
Mechatroniker (m/w/d)
(None specified - new apprenticeship profession being developed)

Responsibilities

Learn various production areas and how solid, semi-solid, and liquid medicinal forms are manufactured
Assist in conducting chemical and physical analyses
Participate in logging and documenting manufacturing processes and results
Acquire knowledge of standards for documenting manufacturing protocols in drug production, as well as handling regulations for occupational, environmental, and health protection
Participate in quality assurance measures
Learn handling and operation of partly complex equipment and machines
Learn analysis of raw materials and medicines
Develop deep understanding of chemical reactions
Acquire knowledge of quality-assuring measures
Learn handling of complex equipment for physico-chemical analyses
Acquire skills in documentation
Engage with areas of occupational safety, health, and environmental protection

Skills

Pharmaceutical Production

Chemical Analysis

Physical Analysis

Documentation

Production Protocols

Sterile Manufacturing

GMP Standards

Peptide Hormones

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free